HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark B Pepys Selected Research

pyrrolidine

1/2018Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
1/2018Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
9/2015Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
3/2010Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.
5/2009Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark B Pepys Research Topics

Disease

26Amyloidosis
12/2021 - 06/2002
14Amyloid Plaque
12/2021 - 03/2007
11Inflammation (Inflammations)
10/2013 - 07/2002
6Cardiovascular Diseases (Cardiovascular Disease)
02/2014 - 08/2003
5Alzheimer Disease (Alzheimer's Disease)
01/2018 - 05/2009
5Acute-Phase Reaction
10/2012 - 07/2002
5Coronary Disease (Coronary Heart Disease)
02/2011 - 08/2003
4Stroke (Strokes)
11/2010 - 11/2004
3Immunoglobulin Light-chain Amyloidosis
01/2017 - 07/2003
3Renal Insufficiency (Renal Failure)
10/2013 - 06/2004
3Proteinuria
03/2010 - 06/2004
3Atherosclerosis
05/2008 - 06/2005
3Infections
04/2006 - 01/2002
2Cardiomyopathies (Cardiomyopathy)
12/2021 - 02/2006
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
02/2016 - 11/2010
2Thrombosis (Thrombus)
01/2008 - 09/2006
2Myocardial Infarction
04/2006 - 11/2004
2Infarction (Infarctions)
04/2006 - 11/2004
2Cerebral Infarction
04/2006 - 11/2004
2Paraproteinemias (Monoclonal Gammopathy)
02/2006 - 07/2003
1Traumatic Brain Injuries (Traumatic Brain Injury)
12/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023
1Transthyretin-Related Hereditary Amyloidosis
12/2021
1Dementia (Dementias)
01/2021
1COVID-19
01/2021
1Disease Progression
09/2015
1Pneumococcal Infections
07/2014
1Ischemic Stroke
01/2010
1Immune Complex Diseases (Immune Complex Disease)
01/2010
1Nephritis
01/2010
1Retinal Drusen
11/2008
1Macular Degeneration (Age-Related Maculopathy)
11/2008
1Systemic Scleroderma (Systemic Sclerosis)
06/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2006
1Necrosis
04/2006
1Hemolytic-Uremic Syndrome
04/2006
1Sepsis (Septicemia)
03/2005
1Vascular Ring
03/2005
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2004
1Obesity
06/2004

Drug/Important Bio-Agent (IBA)

20C-Reactive ProteinIBA
01/2021 - 08/2003
19Serum Amyloid P-ComponentIBA
12/2023 - 01/2002
18Amyloid (Amyloid Fibrils)IBA
12/2021 - 06/2002
15Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2003
12Blood Proteins (Serum Proteins)IBA
12/2021 - 07/2002
10Prealbumin (Transthyretin)IBA
12/2021 - 06/2002
6Complement System Proteins (Complement)IBA
12/2015 - 11/2004
5Carboxylic AcidsIBA
01/2018 - 05/2009
5pyrrolidineIBA
01/2018 - 05/2009
5AntibodiesIBA
01/2017 - 04/2006
5Fibrinogen (Factor I)FDA Link
10/2012 - 06/2002
4Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2018 - 07/2002
3miridesapIBA
01/2018 - 01/2018
3Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2013 - 06/2004
3CholesterolIBA
10/2012 - 04/2004
3Proline (L-Proline)FDA Link
11/2010 - 05/2009
2dezamizumabIBA
01/2018 - 01/2018
2AA amyloidosisIBA
10/2013 - 06/2004
2Doxycycline (Periostat)FDA LinkGeneric
10/2013 - 06/2013
2LigandsIBA
03/2011 - 04/2006
2Antigen-Antibody Complex (Immune Complex)IBA
01/2010 - 06/2004
2ApolipoproteinsIBA
01/2008 - 06/2005
2Apolipoproteins E (ApoE)IBA
01/2008 - 06/2005
2Complement C3 (C3 Complement)IBA
06/2005 - 07/2002
2Estrogens (Estrogen)FDA Link
06/2005 - 01/2003
2cobra venom factorIBA
11/2004 - 07/2002
2Caseins (Casein)FDA Link
12/2003 - 07/2002
1Protein Subunits (Protein Subunit)IBA
12/2021
1FibrinolysinFDA Link
12/2021
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2021
1Serine Proteases (Serine Protease)IBA
12/2021
1Serum AlbuminIBA
01/2021
1Immunoglobulin G (IgG)IBA
09/2015
1Histocompatibility Antigens Class IIBA
10/2013
1Explosive Agents (Explosives)IBA
10/2013
1HDL CholesterolIBA
10/2012
1Biomarkers (Surrogate Marker)IBA
10/2012
1Glycoproteins (Glycoprotein)IBA
11/2010
1AutoantibodiesIBA
01/2010
1Indicators and Reagents (Reagents)IBA
01/2010
1Complement Factor H (Factor H)IBA
11/2008
1fibrinogen AalphaIBA
03/2007
1Peptides (Polypeptides)IBA
03/2007
11,6-bis(phosphocholine)-hexaneIBA
04/2006
1Shiga Toxin (Shigella Toxin)IBA
04/2006
1Shiga Toxin 2IBA
04/2006
1Gonadal Steroid Hormones (Sex Hormones)IBA
06/2005
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2005
1Human Serum AlbuminFDA LinkGeneric
11/2004
1LipidsIBA
06/2004

Therapy/Procedure

4Therapeutics
10/2013 - 01/2010
2Drug Therapy (Chemotherapy)
01/2017 - 07/2003
2Ligation
04/2006 - 11/2004
1Oral Administration
06/2013
1Subcutaneous Injections
01/2010
1Liver Transplantation
03/2007
1Transplantation
03/2007
1Heart Transplantation (Grafting, Heart)
02/2006
1Stem Cell Transplantation
02/2006
1Intravenous Administration
11/2005